(1) Department of Medicine, All India Institute of Medical Science, New-Delhi, 110029, India;(2) Department of Pharmacology, Lady Hardinge Medical College, New-Delhi, 110001, India
Abstract:
Background
Clinical spectrum, microbiology and outcome of empyema thoracis are changing. Intrapleural instillation of fibrinolytic agents is being increasingly used for management of empyema thoracis. The present study was carried out to describe the clinical profile and outcome of patients with empyema thoracis including those with chronic empyema and to study the efficacy and safety of intrapleural streptokinase in its management.
